Riddhi Siddhi Gluco Biols Limited shareholders have approved the shifting of the registered office from Gujarat to Haryana and the alteration of the main object clause of the Memorandum of Association. The special resolutions were passed via a postal ballot and remote e-voting process, which concluded on July 3, 2026. The approvals enable the company to change its domicile and modify its business objectives as outlined in the regulatory filings.

The remote e-voting period was held from June 4, 2026, to July 3, 2026. Mr. Kinjal Shah, Practicing Company Secretary, served as the Scrutinizer for the process and submitted the report to the Board on July 6, 2026. The results were declared in compliance with Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Voting Results

A total of 55,54,387 votes were polled on the resolution to shift the registered office, representing 77.90% of the total outstanding shares. The resolution received 55,54,380 votes in favour and 7 votes against. For the alteration of the main object clause, 55,07,599 votes were polled, representing 77.2477% of the outstanding shares, with 55,07,597 votes in favour and 2 against.

Resolution Breakdown

The Postal Ballot Notice was dated May 25, 2026, and the cut-off date for determining shareholder eligibility was May 29, 2026. The company engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting process. Both resolutions were declared passed as they met the requisite majority requirements under Section 114 of the Companies Act, 2013.

Vital Connections LLP, a promoter group shareholder of Riddhi Siddhi Gluco Biols Ltd, successfully sold 8,23,422 equity shares to achieve Minimum Public Shareholding (MPS) compliance of 25%. The Offer for Sale (OFS), conducted through a separate window on BSE Limited, opened on June 22, 2026, and closed on June 23, 2026. This transaction reduces the aggregate shareholding of the Promoter and Promoter Group from 86.55% to 75% of the paid-up equity share capital, while public shareholding increased to the mandated 25% threshold.

The sale was executed in accordance with SEBI Circular No. SEBI/HO/CFD/PoD2/P/CIR/2023/18 dated February 3, 2023, read with SEBI Circular No. SEBI/HO/MRD/MRD-PoD-3/P/CIR/2023/10 dated January 10, 2023. The initiative follows directives from the Securities and Exchange Board of India (SEBI) and the Securities Appellate Tribunal (SAT) to comply with Rule 19(2)(b) and 19A of the Securities Contracts (Regulation) Rules, 1957, read with Regulation 38 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The shares sold represent 11.55% of the total issued and paid-up equity share capital of the company. Kotak Securities Limited acted as the seller's broker for the transaction. The offer was part of a broader effort to adhere to regulatory requirements regarding minimum public shareholding norms.

Transaction Details

Riddhi Siddhi Gluco Biols Ltd has formally intimated BSE Limited regarding the completion of this offer and the subsequent change in shareholding pattern. The company confirmed that the MPS requirements have been fully met following the closure of the offer window.